Aceto

Aceto in its acquisition of A&C

Client

Aceto

Value

-

Service

Mergers and Acquisitions

Date Closed

April 2021

Industry

Manufacturing

Lead Office

Montréal

 

On April 15, 2021, Aceto, a global provider of specialty materials in the life sciences and advanced technology markets, announced its acquisition of A&C, a GMP (Good Manufacturing Practices) manufacturer specializing in providing pharmaceutical ingredients to the global life sciences industry. The acquisition drives Aceto’s growth strategy by increasing its GMP manufacturing, packaging and ingredients offerings and will allow Aceto to provide its customers with greater access to materials used in the cell culture, vaccine and biopharmaceutical industries. The transaction will also allow Aceto to expand its footprint in North America.

Osler, Hoskin & Harcourt LLP advised Aceto with a team consisting of Shahir Guindi, Matthew Oliver, Véronique Fortin-Latreille (Corporate), Julien Ranger (Pensions & Benefits), Susan Newell (Health), Manon Thivierge (Taxation), Caroline Stephens (Real Estate), Patrick Welsh (Environment), Sam Ip (Technology), Kelly Moffatt (Commercial) and Danielle Chu (Competition/Antitrust & Foreign Investment).